{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:37:45Z","timestamp":1769272665215,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T00:00:00Z","timestamp":1124064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T00:00:00Z","timestamp":1124064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Autoimmune hepatitis (AIH) has been reported to show considerable geographical variation in frequency and clinical manifestations. It is considered a rare cause of liver disease in India. The present study was undertaken to determine the incidence, clinical, biochemical and histological profile of AIH in this part of the world.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Patients presenting with acute or chronic liver disease between January 1999 and June 2002 were evaluated prospectively. AIH was diagnosed using the international autoimmune hepatitis group criteria. Workup included clinical, biochemical, USG, viral markers, UGI endoscopy, AI markers (ANA, SMA, Anti-LKM, AMA, RF, p-ANCA) using indirect immunofluorescence and liver biopsy if possible.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Forty-one of 2401 (1.70%) patients were diagnosed to have autoimmune liver disease. Out of these, 38 had autoimmune hepatitis and the rest 3 had primary biliary cirrhosis. The mean age of the patients of autoimmune hepatitis was 36.2 (15.9) years, 34 (89.4%) were females, and the duration of symptoms was 20.3 (20.5) months. Nineteen (50%) of them presented with chronic hepatitis, 13 (34.2%) as cirrhosis, 5 (13.1%) with acute hepatitis and 1 (2.6%) with cholestatic hepatitis. The presentations were jaundice in 21 (55.2%), pedal edema and hepatomegaly in 17 (44.7%), splenomegaly in 13 (34.2%), encephalopathy, abdominal pain in 9 (23.6%) and fever in 8 (21%). Twelve had esophageal varices and 3 had bled. Biochemical parameters were ALT 187 (360) U\/L, AST 157 (193) U\/L, ALP 246 (254) U\/L, globulin 4.1 (1.6) g\/dL, albumin 2.8 (0.9) g\/dL, bilirubin 5.2 (7.4) mg\/dL, prothrombin time 17 (7) sec and ESR 47 (17) sec. The autoimmune markers were SMA (24), ANA (15), both SMA and ANA (4), AMA (1), rheumatoid factor (2), pANCA (1), and Anti-LKM in none. Thirty (79%) patients had definite AIH and eight (21%) had probable AI hepatitis. Associated autoimmune diseases was seen in 15\/38 (39.4%), diabetes 4, hypothyroidism 3, vitiligo 2, thrombocytopenia 2, rheumatoid arthritis 2, Sjogren's syndrome 1 and autoimmune polyglandular syndrome III in 1. Viral markers were positive in two patients, one presenting as acute hepatitis and HEV-IgM positive and another anti-HCV positive.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>In India, autoimmune hepatitis is uncommon and usually presents with chronic hepatitis or cirrhosis, acute hepatitis being less common. Age at presentation was earlier but clinical parameters and associated autoimmune diseases were similar to that reported from the west. Primary biliary cirrhosis is rare. Type II AIH was not observed.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-230x-5-27","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T06:13:54Z","timestamp":1124259234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Autoimmune hepatitis in India: profile of an uncommon disease"],"prefix":"10.1186","volume":"5","author":[{"given":"Gourdas","family":"Choudhuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalamalasetty S","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,15]]},"reference":[{"key":"132_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF02065434","volume":"40","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ: Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci. 1995, 40: 435-438. 10.1007\/BF02065434.","journal-title":"Dig Dis Sci"},{"key":"132_CR2","first-page":"143","volume-title":"Autoimmune liver disease","author":"AJ Czaja","year":"1991","unstructured":"Czaja AJ: Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis. Autoimmune liver disease. Edited by: Krawitt EL, Weisner RH. 1991, New York, Raven Press, 143-"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2008-1040641","volume":"4","author":"AJ Czaja","year":"1984","unstructured":"Czaja AJ: Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis. 1984, 4: 1-","journal-title":"Semin Liver Dis"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG: Meeting report: International autoimmune hepatitis group. Hepatology. 1993, 18: 998-1005.","journal-title":"Hepatology"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofangale HH, Kajumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M: International autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31: 929-938. 10.1016\/S0168-8278(99)80297-9.","journal-title":"J Hepatol"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/gast.2001.24227","volume":"120","author":"MP Manns","year":"2001","unstructured":"Manns MP, Strassburg CP: Autoimmune hepatitis: Clinical challenges. Gastroenterology. 2001, 120: 1502-1517. 10.1053\/gast.2001.24227.","journal-title":"Gastroenterology"},{"key":"132_CR7","first-page":"1","volume-title":"Comprehensive clinical Hepatology","author":"MP Manns","year":"2000","unstructured":"Manns MP, Strassburg CP: Autoimmune hepatitis. Comprehensive clinical Hepatology. Edited by: O'Grady JG, Lake JR, Howdle DP. 2000, London: Mosby, 16: 1-14."},{"key":"132_CR8","first-page":"325","volume":"27","author":"HP Dienes","year":"1989","unstructured":"Dienes HP, Popper H, Manns M, Baumann W, Thoenes W, Meyer zum Buschenfelde KH: Histologic features in autoimmune hepatitis. Z Gastroenterol. 1989, 27: 325-330.","journal-title":"Z Gastroenterol"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, et al: Epidemiology and estimated population burden of selected autoimmune diseases in United States. Clin Immunol Immunopathol. 1997, 84: 223-245. 10.1006\/clin.1997.4412.","journal-title":"Clin Immunol Immunopathol"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1046\/j.1440-1746.2001.02602.x","volume":"16","author":"R Gupta","year":"2001","unstructured":"Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK: Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol. 2001, 16: 1144-1148. 10.1046\/j.1440-1746.2001.02602.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"132_CR11","first-page":"65","volume":"3","author":"A Agarwal","year":"1995","unstructured":"Agarwal A, Singh RR, Misra R: Chronic active hepatitis with multisystem disease: Lupoid hepatitis or systemic lupus erythematosus?. J Ind Rheum Assoc. 1995, 3: 65-66.","journal-title":"J Ind Rheum Assoc"},{"key":"132_CR12","first-page":"431","volume":"46","author":"C Balakrishnan","year":"1998","unstructured":"Balakrishnan C, Mangat G, Kalke S, Desai D, Joshi A, Deshpande RB, Joshi VR: The spectrum of chronic autoimmune hepatitis. J Assoc Physicians Iindia. 1998, 46: 431-435.","journal-title":"J Assoc Physicians Iindia"},{"key":"132_CR13","first-page":"1064","volume":"48","author":"DN Amrapurar","year":"2000","unstructured":"Amrapurar DN, Amrapurkar AD: Role of autoimmunity in nonviral chronic liver disease. JAPI. 2000, 48: 1064-1069.","journal-title":"JAPI"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Wantanabe F, Imawari M, Kiyosawa K, Nishioka M, Tsuji T, Omata M, the Japanese national Study Group of Autoimmune Hepatitis: Present status of autoimmune hepatitis in Japan- correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol. 1997, 26: 1207-1212. 10.1016\/S0168-8278(97)80453-9.","journal-title":"J Hepatol"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","volume":"13","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Yoneda M, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Hasegawa T, Makino I: Efficacy of Ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol. 1998, 13: 490-495.","journal-title":"J Gastroenterol Hepatol"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","volume":"18","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, et al: Evidence against hepatitis viruses as important cause of severe autoimmune hepatitis in United States. J Hepatol. 1993, 18: 342-10.1016\/S0168-8278(05)80279-X.","journal-title":"J Hepatol"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0025-7125(05)70476-4","volume":"80","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ: Diagnosis and therapy of autoimmune liver disease. Med Clin North Am. 1996, 80: 973-94.","journal-title":"Med Clin North Am"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"GA Nikias","year":"1994","unstructured":"Nikias GA, Batts KP, Czaja AJ: The nature and prognostic implication of autoimmune hepatitis with acute presentation. J Hepatol. 1994, 19: 1513-1520. 10.1016\/0270-9139(94)90250-X.","journal-title":"J Hepatol"},{"key":"132_CR19","first-page":"331","volume-title":"Autoimmune liver diseases","author":"D Zauli","year":"1998","unstructured":"Zauli D, Cassani F, Muratori L, et al: Autoantibodies in hepatitis C. Autoimmune liver diseases. Edited by: Krawitt EL, Wiesner RS, Nishioka M. 1998, Amsterdam: Elsevier Science, 331-341. 2","edition":"2"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/jhep.2001.23316","volume":"33","author":"J Woodward","year":"2001","unstructured":"Woodward J, Neuberger J: Autoimmune Overlap Syndromes. Hepatology. 2001, 33: 994-1001. 10.1053\/jhep.2001.23316.","journal-title":"Hepatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-230X-5-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:00:34Z","timestamp":1728306034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-5-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-5-27","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]},"assertion":[{"value":"30 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}